Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
about
Inflammatory bowel disease and cancer: The role of inflammation, immunosuppression, and cancer treatmentCurrent approaches for optimizing the benefit of biologic therapy in ulcerative colitisUse of biologics and chemotherapy in patients with inflammatory bowel diseases and cancerThiopurines and inflammatory bowel disease: Current evidence and a historical perspectiveCancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.Anti-TNFα therapy for chronic inflammatory disease in kidney transplant recipients: Clinical outcomesIncidental adenocarcinoma in patients undergoing surgery for stricturing Crohn's disease.Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.Management of Inflammatory Bowel Disease in the Elderly.Understanding the Cautions and Contraindications of Immunomodulator and Biologic Therapies for Use in Inflammatory Bowel Disease.Inflammatory bowel disease, cancer and medication: Cancer risk in the Dutch population-based IBDSL cohort.Association Between Breast Cancer Recurrence and Immunosuppression in Rheumatoid Arthritis and Inflammatory Bowel Disease: A Cohort Study.Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD.
P2860
Q26745456-8FA441FD-CA15-4A16-92D6-6C059E294DAFQ26745712-D21D7B25-A4C7-4F11-85FC-7CACA9BFF35EQ26750190-27EFDA06-524A-4311-8C2F-E72F356BC311Q28079644-3D76A0BD-BF85-46F4-A650-332DD8EFB237Q34520662-D194760A-AE6A-4175-A668-92F67A01F1CDQ37354812-AF824F3C-5700-4DBF-8B1F-EB34B4BCBBCBQ37624501-61E08568-7E00-46EA-A193-42753967D985Q38735146-06A0D31B-5393-4691-ACBF-106CB43FBEEEQ38844393-94B7F812-0507-4F29-A873-845CB1167775Q39435409-3D44E5C3-F743-4AEC-9135-82DF3E966E0FQ39773210-804E89C4-4786-4158-9D46-56BE914487AAQ39783472-F660098B-E916-4348-A8F0-8D2064660602Q49292225-602A3805-E66C-4863-A083-F2B467F0773A
P2860
Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Risk of New or Recurrent Cance ...... -Tumor Necrosis Factor Agents.
@en
type
label
Risk of New or Recurrent Cance ...... -Tumor Necrosis Factor Agents.
@en
prefLabel
Risk of New or Recurrent Cance ...... -Tumor Necrosis Factor Agents.
@en
P2093
P50
P1476
Risk of New or Recurrent Cance ...... -Tumor Necrosis Factor Agents.
@en
P2093
Amit Desai
Andre Reyes
Ashwin Ananthakrishnan
Burton Korelitz
David DiCaprio
Elisa McEachern
Ellen Scherl
Erwin Wang
Gila Hoffman
Hina Zaidi
P356
10.1016/J.CGH.2015.07.037
P407
P577
2015-08-03T00:00:00Z